Please login to the form below

Not currently logged in
Email:
Password:

Mylan facing US anticompetitive practice probe

Senate judiciary committee calls for fair competition review over EpiPen sales
Mylan

Two leading members of the US Senate Judiciary Committee have called for an investigation into Mylan's adherence to market competition laws over its EpiPen sales practices.

The committee's chairman Charles Grassley and member Patrick Leahy have requested that the US' Federal Trade Commission (FTC) launch an antitrust probe into whether the firm prevented schools from purchasing rival allergy treatments.

In a letter to the federal antitrust regulator, Grassley and Leahy said the agency should look into exclusive school contracts for restrictions regarding EpiPen competitors.

Addressed to FTC chairwoman Edith Ramirez, its states: “Increasing patient access to safe, effective and affordable medications has long been a shared priority of ours.

“We also share a strong belief that potential anti-competitive actions by drug industry participants must be aggressively investigated because of their impact on competition and drug costs.

“We therefore request that the FTC look into whether Mylan engaged in any anti-competitive practices in violation of the antitrust laws with respect to the EpiPen, and, if so, take appropriate action to safeguard patients.”

The new inquiry adds to the ongoing scrutiny over Mylan's EpiPen, which has been at the centre of a public drug pricing scandal after protests against its 400% price increase over the past six years.

Mylan has since extended its patient access schemes in the US and committed to the production of a generic version of the emergency anti-allergy injector priced at less than half the two-pen pack's current list price.

The US firm has also proposed a $465m settlement to address claims it underpaid state and federal Medicaid rebates by misclassifying the treatment, which is due to be considered by the Judiciary Committee in the next few weeks.

Article by
Rebecca Clifford

8th November 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...